 AUSTIN, Texas, Sept. 08, 2022 GLOBE NEWSWIRE -- Cassava Sciences, Inc. Nasdaq: SAVA, a clinical-stage biotechnology company focused on Alzheimers disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held in New York. 